SETAC-EU 2021 -- Honeybee toxicity studies are an essential requirement in today's regulatory climate. In particular, field and semi-field trials are very high value Terrestrial Ecotoxicology study types that continue to be in ever-increasing demand from global customers.

Benefit of using the DCT Investigator Network

This white paper provides an overview of CDx, compares development and regulatory paths and discusses the challenges faced in commercialization, utilization and uptake of these tests.

CYTO 2021 -- With the progress in drug development for cancer immunotherapy, a comprehensive evaluation and scoring of solid tumors resected from patients will allow for optimization and selection of most beneficial therapies and provide insights for personalized medicine.

CYTO 2021 -- Regulatory T cells (Treg) represent a distinct subpopulation of T cells involved in the modulation of immune responses to pathogens, allergens, and auto-antigens.1,2 They suppress inflammation by inhibiting both T cell proliferation and cytokine production.

Keeping up-to-date on regulatory changes and performing sufficient groundwork to allow rapid implementation of new testing requirements is crucial to providing exceptional service to our our clients.

Patients' real-life experiences and needs are increasingly being incorporated into the design of clinical trials to strengthen drug development programs and inform regulatory guidance, while also helping healthcare providers and care partners recognize current gaps in care. Elevating the voice of the patient (VoP) and providing more patient-centric care is

Phase I hybrid trials are early clinical studies combining both healthy normal volunteers (HNVs) and patients from the target indication in one protocol. These trials can be extraordinarily valuable, as they can deliver important insights regarding a drug's pharmacodynamic (PD) effects and therapeutic potential at a very early stage in development.

Using a cGMP pharmacy at your Clinical Research Unit (CRU) for Phase I drug manufacturing yields benefits in quality and safety, timeline reduction and cost efficiency.

Labcorp data can help accelerate your studies. Labcorp data is comprised of four powerful data sets: Labcorp De-Identified Lab Result Data, Labcorp Central Labs Investigator Data, Patient Direct and Patient Intelligence.